Clearing Up Concerns Over Vicks VapoRub

A new study raised concerns recently over safety of the popular ointment Vicks VapoRub in young children. Wake Forest University researchers report that the salve, which is used to relieve symptoms of cough and chest congestion, may actually stimulate mucus production and airway inflammation in infants and toddlers [1]. However, the results are far from conclusive as the study was based on the case of a single child and 15 animals. Moreover, many of the results of the study have been incorrectly reported by the media.